Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001641172-25-023728
Filing Date
2025-08-14
Accepted
2025-08-14 08:01:10
Documents
58
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q form10-q.htm   iXBRL 10-Q 559606
2 EX-31.1 ex31-1.htm EX-31.1 11919
3 EX-31.2 ex31-2.htm EX-31.2 11777
4 EX-31.3 ex31-3.htm EX-31.3 7934
5 EX-32.1 ex32-1.htm EX-32.1 10338
6 GRAPHIC form10-q_002.jpg GRAPHIC 70291
  Complete submission text file 0001641172-25-023728.txt   3700590

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE cocp-20250630.xsd EX-101.SCH 25243
8 XBRL CALCULATION FILE cocp-20250630_cal.xml EX-101.CAL 39170
9 XBRL DEFINITION FILE cocp-20250630_def.xml EX-101.DEF 100273
10 XBRL LABEL FILE cocp-20250630_lab.xml EX-101.LAB 281660
11 XBRL PRESENTATION FILE cocp-20250630_pre.xml EX-101.PRE 224552
60 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 392849
Mailing Address 19805 N. CREEK PARKWAY BOTHELL WA 98011
Business Address 19805 N. CREEK PARKWAY BOTHELL WA 98011 (786) 459-1831
Cocrystal Pharma, Inc. (Filer) CIK: 0001412486 (see all company filings)

EIN.: 352528215 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38418 | Film No.: 251214452
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)